PMWC 2017 Silicon Valley Session Themes

How To Engage Community Oncologists in Precision Medicine Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair

How To Engage Community Oncologists in Precision Medicine

Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair

Companion Diagnostics: Where is the Incentive? Session Chair: Ed Winnick, GenomeWeb

Companion Diagnostics: Where is the Incentive?

Session Chair: Ed Winnick, GenomeWeb

Immunotherapy: Emerging Applications and Therapies Session Chair: James Allison, MD Anderson Cancer Center

Immunotherapy: Emerging Applications and Therapies

Session Chair: James Allison, MD Anderson Cancer Center

Integrating Precision Medicine: Technical Challenges and Solutions Session Chair: Eric Dishman, NIH

Integrating Precision Medicine: Technical Challenges and Solutions

Session Chair: Eric Dishman, NIH

The Economics of Bringing Precision Medicine to the Clinic Session Chair: George Poste, ASU

The Economics of Bringing Precision Medicine to the Clinic

Session Chair: George Poste, ASU

Genetic Testing In Healthy Population Session Chair: Randy Scott, Invitae

Genetic Testing In Healthy Population

Session Chair: Randy Scott, Invitae

The Secret to Wellness is Science Session Chair: Lee Hood, Providence Health

The Secret to Wellness is Science

Session Chair: Lee Hood, Providence Health

Human Biospecimen Acquisition; Risks, Challenges and Solutions Session Chair: Matt McLoughlin, Scientist.com

Human Biospecimen Acquisition; Risks, Challenges and Solutions

Session Chair: Matt McLoughlin, Scientist.com

ME/CFS: The Mysterious Illness Science Has Yet to Unravel Session Chair: Zaher Nahle, Solve ME/CFS Initiative

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

Session Chair: Zaher Nahle, Solve ME/CFS Initiative

Adoption of Precision Medicine: Hereditary Cancer Session Chair: Taylor Sittler, Color Genomics

Adoption of Precision Medicine: Hereditary Cancer

Session Chair: Taylor Sittler, Color Genomics

CIAPM: Accelerating Precision Medicine Advances in California Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM

CIAPM: Accelerating Precision Medicine Advances in California

Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM

How to Commercialize Disruptive Technologies That Advance Precision Medicine Session Chair: Alex De Winter, GE Ventures

How to Commercialize Disruptive Technologies That Advance Precision Medicine

Session Chair: Alex De Winter, GE Ventures

Let’s talk mHealth And Telehealth And Their Impact On Our Lives Session Chair: Ida Sim, UCSF

Let’s talk mHealth And Telehealth And Their Impact On Our Lives

Session Chair: Ida Sim, UCSF

Tumor Profiling to Clinical Action Session Chair: Wolfgang Daum, Toma Biosciences

Tumor Profiling to Clinical Action

Session Chair: Wolfgang Daum, Toma Biosciences

Scaling the 26-Hour Genome Session Chair: Pieter van Rooyen, Edico Genome

Scaling the 26-Hour Genome

Session Chair: Pieter van Rooyen, Edico Genome

Patient Power: The Changing Role of Individuals Session Chair: Cliff Reid, Genos Research

Patient Power: The Changing Role of Individuals

Session Chair: Cliff Reid, Genos Research

Progress in Improving the Evidence Base and Insurer Coverage Session Chair: Kathryn Phillips, UCSF

Progress in Improving the Evidence Base and Insurer Coverage

Session Chair: Kathryn Phillips, UCSF

Medical Devices and IoT: the Bridge to the Phenotype Session Chair: Sanjay Joshi, Dell EMC

Medical Devices and IoT: the Bridge to the Phenotype

Session Chair: Sanjay Joshi, Dell EMC

An Update on the Cancer Moonshot Blood Profiling Atlas Session Chair: Bruce Press, Seven Bridges

An Update on the Cancer Moonshot Blood Profiling Atlas

Session Chair: Bruce Press, Seven Bridges

An Update on the Cancer Moonshot and Brain Government Initiatives Session Chair: Joshua Gordon, National Institute of Mental Health

An Update on the Cancer Moonshot and Brain Government Initiatives

Session Chair: Joshua Gordon, National Institute of Mental Health

Data Sharing: Patient Rights and Privacy Session Chair: William Knox Carey, Genecloud

Data Sharing: Patient Rights and Privacy

Session Chair: William Knox Carey, Genecloud

Enabling Advances in Human Microbiome Research Session Chair: Nick Conley, Epibiome

Enabling Advances in Human Microbiome Research

Session Chair: Nick Conley, Epibiome

Biobanking Your Future Session Chair: Nazneen Aziz, Kaiser Permanente

Biobanking Your Future

Session Chair: Nazneen Aziz, Kaiser Permanente

Health Systems as Translational Research Partners Session Chair: Walter “Buzz” Stewart, Sutter Health

Health Systems as Translational Research Partners

Session Chair: Walter “Buzz” Stewart, Sutter Health

How Molecular Subtyping Can Aid Clinical Drug Development Session Chair: Janusz Dutkowski, Data4Cure

How Molecular Subtyping Can Aid Clinical Drug Development

Session Chair: Janusz Dutkowski, Data4Cure

Precision Measurement in Biology Session Chair: Stephen Quake, Stanford University

Precision Measurement in Biology

Session Chair: Stephen Quake, Stanford University

NGS: Implementing a Clinical Workflow for All Constituents Session Chair: Matthew Tindall, Omicia

NGS: Implementing a Clinical Workflow for All Constituents

Session Chair: Matthew Tindall, Omicia

How Scientific Wellness Will Transform Healthcare Session Chair: Lee Hood, Providence Health

How Scientific Wellness Will Transform Healthcare

Session Chair: Lee Hood, Providence Health

Understanding Human Health and Diseases at the Individual Level Session Chair: Euan Ashley, Stanford Clinical Genomics Service

Understanding Human Health and Diseases at the Individual Level

Session Chair: Euan Ashley, Stanford Clinical Genomics Service

Learnings from Precision Medicine Centers Session Chair: Berta Strulovici, Weizmann Institute

Learnings from Precision Medicine Centers

Session Chair: Berta Strulovici, Weizmann Institute

How to Make Rx-Dx Alliances Work Session Chair: Myla Lai-Goldman, GeneCentric; Eric Lai, Takeda

How to Make Rx-Dx Alliances Work

Session Chair: Myla Lai-Goldman, GeneCentric; Eric Lai, Takeda

The Value of Data Sharing Session Chair: John Leite, Illumina; John Shon, Illumina

The Value of Data Sharing

Session Chair: John Leite, Illumina; John Shon, Illumina

Population Precision Medicine Session Chair: Kirsten Bibbins-Domingo, UCSF

Population Precision Medicine

Session Chair: Kirsten Bibbins-Domingo, UCSF

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges Session Chair: Walter Koch, Roche

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges

Session Chair: Walter Koch, Roche

Personalized Medicine – The Cinderella Story of Venture Investments? Session Chair: Mara Aspinall, Genepeeks

Personalized Medicine – The Cinderella Story of Venture Investments?

Session Chair: Mara Aspinall, Genepeeks

How Immuno-oncology Saved My Life: A Patient’s Perspective Session Chair: Andrew Schorr, Patient Power

How Immuno-oncology Saved My Life: A Patient’s Perspective

Session Chair: Andrew Schorr, Patient Power

Developing Successful Predictive Clinical Biomarkers Session Chair: Ann Kapoun, Oncomed

Developing Successful Predictive Clinical Biomarkers

Session Chair: Ann Kapoun, Oncomed

Achieving Accurate NGS Test Results Session Chair: Russell Garlick, SeraCare

Achieving Accurate NGS Test Results

Session Chair: Russell Garlick, SeraCare

Clinical Trials in Immunotherapy Session Chair: Patrice Hugo, Q2 Solutions

Clinical Trials in Immunotherapy

Session Chair: Patrice Hugo, Q2 Solutions

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology Session Chair: Brad Gray, NanoString Technologies

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology

Session Chair: Brad Gray, NanoString Technologies

Generating Insights from Multi-modal Healthcare Data for Precision Medicine Session Chair: Atul Butte, UCSF

Generating Insights from Multi-modal Healthcare Data for Precision Medicine

Session Chair: Atul Butte, UCSF

Issues and Challenges of Immunotherapy Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center

Issues and Challenges of Immunotherapy

Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care Session Chair: Assaf Halevy, 2bPrecise

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care

Session Chair: Assaf Halevy, 2bPrecise

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine Session Chair: John Ryals, Metabolon

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine

Session Chair: John Ryals, Metabolon

Implementing Precision Medicine Programs: Real-world Solutions to Practical Challenges Session Chair: Chris Cournoyer, N-of-One

Implementing Precision Medicine Programs: Real-world Solutions to Practical Challenges

Session Chair: Chris Cournoyer, N-of-One

Unlocking Real-World Clinical Data Session Chair: Amy Abernethy, Flatiron Health

Unlocking Real-World Clinical Data

Session Chair: Amy Abernethy, Flatiron Health

Immunotherapy: Immunocheckpoint Inhibitors & Beyond Session Chair: Irv Weissman, Stanford School of Medicine

Immunotherapy: Immunocheckpoint Inhibitors & Beyond

Session Chair: Irv Weissman, Stanford School of Medicine

Emerging Themes in the Human Microbiome Session Chair: Michael Fischbach, UCSF

Emerging Themes in the Human Microbiome

Session Chair: Michael Fischbach, UCSF

Expanding the Reach of Genomic Analysis Session Chair: Deanna Church, 10x Genomics

Expanding the Reach of Genomic Analysis

Session Chair: Deanna Church, 10x Genomics

Precision Medicine Patent Law Update Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West

Precision Medicine Patent Law Update

Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West

New Healthcare Paradigm from the $100 Genome Session Chair: Yiwu He, BGI

New Healthcare Paradigm from the $100 Genome

Session Chair: Yiwu He, BGI

Beyond Genomics for Predicting Patient Response Session Chair: Parker Cassidy, Mitra Biotech

Beyond Genomics for Predicting Patient Response

Session Chair: Parker Cassidy, Mitra Biotech

Building Value for Liquid Biopsies in Oncology Session Chair: Frederic Pla, Genomic Health

Building Value for Liquid Biopsies in Oncology

Session Chair: Frederic Pla, Genomic Health

Large Scale Human Genetics in Genomic Medicine and Drug Discovery Session Chair: Aris Baras, Regeneron

Large Scale Human Genetics in Genomic Medicine and Drug Discovery

Session Chair: Aris Baras, Regeneron

Rare Disease Drug Development in Precision Medicine Session Chair: Mary Dixon Drake, Innovenn

Rare Disease Drug Development in Precision Medicine

Session Chair: Mary Dixon Drake, Innovenn

Clinical Next-Gen Sequencing for Infectious Disease Diagnosis Session Chair: Charles Chiu, UCSF

Clinical Next-Gen Sequencing for Infectious Disease Diagnosis

Session Chair: Charles Chiu, UCSF

Diagnostics Policy and the Impact on Innovation Session Chair: Michael W. Nall, Biocept

Diagnostics Policy and the Impact on Innovation

Session Chair: Michael W. Nall, Biocept

Pathogen Specific Biologics for Infectious Diseases Session Chair: Steven J. Projan, Medimmune

Pathogen Specific Biologics for Infectious Diseases

Session Chair: Steven J. Projan, Medimmune

Importance of Standardized Assays for Precision Medicine Session Chair: Jeffrey Edward Miller, Invivoscribe

Importance of Standardized Assays for Precision Medicine

Session Chair: Jeffrey Edward Miller, Invivoscribe

Complementary Use of Digital PCR and NGS in Cancer Liquid Biopsy Session Chair: George Karlin-Neumann, BioRad

Complementary Use of Digital PCR and NGS in Cancer Liquid Biopsy

Session Chair: George Karlin-Neumann, BioRad

Moving Precision Medicine to Precision Health Session Chair: Harold L. Paz, Aetna

Moving Precision Medicine to Precision Health

Session Chair: Harold L. Paz, Aetna

Clinical Applications of ctDNA in Cancer Management Session Chair: Clive Morris, Inivata

Clinical Applications of ctDNA in Cancer Management

Session Chair: Clive Morris, Inivata

Next-Generation Liquid Biopsy Testing: Promise and Limitations Session Chair: Jason Myers, ArcherDX

Next-Generation Liquid Biopsy Testing: Promise and Limitations

Session Chair: Jason Myers, ArcherDX

Emerging Infections: Tracking, Testing and Public Health Response Session Chair: Steve Miller, UCSF

Emerging Infections: Tracking, Testing and Public Health Response

Session Chair: Steve Miller, UCSF

Advancing the Clinic with Emerging NGS Technologies Session Chair: Allison Ballmer, Roche

Advancing the Clinic with Emerging NGS Technologies

Session Chair: Allison Ballmer, Roche

See Program Schedule ->

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.

We hate spam too, unsubscribe at any time.

Do not alert me again.